In contrast, despite recent studies demonstrating an important role for extra-lymphoid CD8+ T cell-cDC cross-talk in maintaining robust anti-viral and anti-tumour immunity34–36, studies investigating the role of cognate DC licensing in non-lymphoid peripheral tissues, once activated T cells have left SLOs, have been lacking. Here, CD8A is linked to neoplasm.